14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:FPRX
Delisted

Five Prime Therapeutics Stock Price (Quote)

$38.00
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $38.00 $38.00 Friday, 27th May 2022 FPRX stock ended at $38.00. During the day the stock fluctuated 0% from a day low at $38.00 to a day high of $38.00.
90 days $38.00 $38.00
52 weeks $38.00 $38.00

Historical Five Prime Therapeutics prices

Date Open High Low Close Volume
May 27, 2022 $38.00 $38.00 $38.00 $38.00 0
May 26, 2022 $38.00 $38.00 $38.00 $38.00 0
May 25, 2022 $38.00 $38.00 $38.00 $38.00 0
May 24, 2022 $38.00 $38.00 $38.00 $38.00 0
May 23, 2022 $38.00 $38.00 $38.00 $38.00 0
May 20, 2022 $38.00 $38.00 $38.00 $38.00 0
May 19, 2022 $38.00 $38.00 $38.00 $38.00 0
May 18, 2022 $38.00 $38.00 $38.00 $38.00 0
May 17, 2022 $38.00 $38.00 $38.00 $38.00 0
May 16, 2022 $38.00 $38.00 $38.00 $38.00 0
May 13, 2022 $38.00 $38.00 $38.00 $38.00 0
May 12, 2022 $38.00 $38.00 $38.00 $38.00 0
May 11, 2022 $38.00 $38.00 $38.00 $38.00 0
May 10, 2022 $38.00 $38.00 $38.00 $38.00 0
May 09, 2022 $38.00 $38.00 $38.00 $38.00 0
May 06, 2022 $38.00 $38.00 $38.00 $38.00 0
May 05, 2022 $38.00 $38.00 $38.00 $38.00 0
May 04, 2022 $38.00 $38.00 $38.00 $38.00 0
May 03, 2022 $38.00 $38.00 $38.00 $38.00 0
May 02, 2022 $38.00 $38.00 $38.00 $38.00 0
Apr 29, 2022 $38.00 $38.00 $38.00 $38.00 0
Apr 28, 2022 $38.00 $38.00 $38.00 $38.00 0
Apr 27, 2022 $38.00 $38.00 $38.00 $38.00 0
Apr 26, 2022 $38.00 $38.00 $38.00 $38.00 0
Apr 25, 2022 $38.00 $38.00 $38.00 $38.00 0
Click to get the best stock tips daily for free!

About Five Prime Therapeutics

Five Prime Therapeutics Five Prime Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of protein therapeutics that block cancer and inflammatory disease processes in the United States. The company’s product candidates include FPA008, an antibody that inhibits colony stimulating factor-1 receptor and is in Phase Ia/Ib clinical trials for the treatment of various cancers in combination with nivolumab; and is in Phase I/II... FPRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT